High Sierra Technologies, Inc. (HSTI)
USD 0.25
(0.0%)
USD 0.25
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | 611.78 Thousand USD | 4.64% |
| 2021 | 584.67 Thousand USD | 12.46% |
| 2020 | 519.89 Thousand USD | 16.13% |
| 2019 | 447.67 Thousand USD | 1660.82% |
| 2018 | 25.42 Thousand USD | -94.09% |
| 2017 | 429.97 Thousand USD | 12.01% |
| 2016 | 383.86 Thousand USD | 11.94% |
| 2015 | 342.91 Thousand USD | 17.93% |
| 2014 | 290.77 Thousand USD | 14.91% |
| 2013 | 253.04 Thousand USD | 14.65% |
| 2012 | 220.71 Thousand USD | 15.21% |
| 2011 | 191.57 Thousand USD | 16.33% |
| 2010 | 164.68 Thousand USD | 15.11% |
| 2009 | 143.06 Thousand USD | 17.39% |
| 2008 | 121.87 Thousand USD | 19.21% |
| 2007 | 102.23 Thousand USD | 16.94% |
| 2006 | 87.42 Thousand USD | 55.43% |
| 2005 | 56.24 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q1 | 683.03 Thousand USD | 11.65% |
| 2023 Q3 | 822.61 Thousand USD | 12.51% |
| 2023 Q2 | 731.12 Thousand USD | 7.04% |
| 2022 FY | 611.78 Thousand USD | 4.64% |
| 2022 Q3 | 713.88 Thousand USD | 4.26% |
| 2022 Q2 | 684.72 Thousand USD | -1.72% |
| 2022 Q1 | 696.7 Thousand USD | 19.16% |
| 2022 Q4 | 611.78 Thousand USD | -14.3% |
| 2021 Q2 | 554.1 Thousand USD | 4.39% |
| 2021 Q3 | 660.21 Thousand USD | 19.15% |
| 2021 Q4 | 584.67 Thousand USD | -11.44% |
| 2021 FY | 584.67 Thousand USD | 12.46% |
| 2021 Q1 | 530.82 Thousand USD | 2.1% |
| 2020 Q3 | 455.03 Thousand USD | -6.25% |
| 2020 FY | 519.89 Thousand USD | 16.13% |
| 2020 Q1 | 462.16 Thousand USD | 3.24% |
| 2020 Q2 | 485.36 Thousand USD | 5.02% |
| 2020 Q4 | 519.89 Thousand USD | 14.25% |
| 2019 Q4 | 447.67 Thousand USD | -16.37% |
| 2019 Q2 | 218.22 Thousand USD | 687.71% |
| 2019 Q1 | 27.7 Thousand USD | 8.97% |
| 2019 Q3 | 535.31 Thousand USD | 145.3% |
| 2019 FY | 447.67 Thousand USD | 1660.82% |
| 2018 Q1 | 436.45 Thousand USD | 1.51% |
| 2018 Q4 | 25.42 Thousand USD | -95.07% |
| 2018 FY | 25.42 Thousand USD | -94.09% |
| 2018 Q2 | 954.68 Thousand USD | 118.74% |
| 2018 Q3 | 515.82 Thousand USD | -45.97% |
| 2017 Q3 | 420.31 Thousand USD | 2.38% |
| 2017 FY | 429.97 Thousand USD | 12.01% |
| 2017 Q1 | 393.18 Thousand USD | 2.43% |
| 2017 Q4 | 429.97 Thousand USD | 2.3% |
| 2017 Q2 | 410.52 Thousand USD | 4.41% |
| 2016 Q3 | 374.83 Thousand USD | 2.92% |
| 2016 Q4 | 383.86 Thousand USD | 2.41% |
| 2016 FY | 383.86 Thousand USD | 11.94% |
| 2016 Q2 | 364.21 Thousand USD | 4.11% |
| 2016 Q1 | 349.84 Thousand USD | 2.02% |
| 2015 Q4 | 342.91 Thousand USD | 3.17% |
| 2015 Q1 | 298.53 Thousand USD | 2.67% |
| 2015 FY | 342.91 Thousand USD | 17.93% |
| 2015 Q2 | 325.13 Thousand USD | 8.91% |
| 2015 Q3 | 332.37 Thousand USD | 2.23% |
| 2014 Q3 | 279.05 Thousand USD | 3.83% |
| 2014 Q4 | 290.77 Thousand USD | 4.2% |
| 2014 Q1 | 262.6 Thousand USD | 3.78% |
| 2014 Q2 | 268.77 Thousand USD | 2.35% |
| 2014 FY | 290.77 Thousand USD | 14.91% |
| 2013 Q1 | 224.83 Thousand USD | 1.87% |
| 2013 FY | 253.04 Thousand USD | 14.65% |
| 2013 Q4 | 253.04 Thousand USD | 2.98% |
| 2013 Q3 | 245.72 Thousand USD | 3.33% |
| 2013 Q2 | 237.81 Thousand USD | 5.77% |
| 2012 Q4 | 220.71 Thousand USD | 3.17% |
| 2012 Q3 | 213.92 Thousand USD | 4.03% |
| 2012 Q2 | 205.63 Thousand USD | 3.46% |
| 2012 FY | 220.71 Thousand USD | 15.21% |
| 2012 Q1 | 198.75 Thousand USD | 3.75% |
| 2011 FY | 191.57 Thousand USD | 16.33% |
| 2011 Q4 | 191.57 Thousand USD | 3.92% |
| 2011 Q3 | 184.34 Thousand USD | 3.08% |
| 2011 Q2 | 178.84 Thousand USD | 3.54% |
| 2011 Q1 | 172.73 Thousand USD | 4.89% |
| 2010 Q1 | 148.05 Thousand USD | 3.49% |
| 2010 Q4 | 164.68 Thousand USD | 3.03% |
| 2010 Q3 | 159.83 Thousand USD | 2.64% |
| 2010 FY | 164.68 Thousand USD | 15.11% |
| 2010 Q2 | 155.72 Thousand USD | 5.18% |
| 2009 Q3 | 138.63 Thousand USD | 2.98% |
| 2009 FY | 143.06 Thousand USD | 17.39% |
| 2009 Q4 | 143.06 Thousand USD | 3.2% |
| 2009 Q1 | 128.96 Thousand USD | 5.82% |
| 2009 Q2 | 134.61 Thousand USD | 4.39% |
| 2008 Q4 | 121.87 Thousand USD | 2.94% |
| 2008 Q2 | 117.86 Thousand USD | 9.5% |
| 2008 Q1 | 107.64 Thousand USD | 5.29% |
| 2008 FY | 121.87 Thousand USD | 19.21% |
| 2008 Q3 | 118.39 Thousand USD | 0.45% |
| 2007 Q2 | 96.34 Thousand USD | 10.82% |
| 2007 Q4 | 102.23 Thousand USD | 2.71% |
| 2007 FY | 102.23 Thousand USD | 16.94% |
| 2007 Q1 | 86.93 Thousand USD | -0.56% |
| 2007 Q3 | 99.53 Thousand USD | 3.32% |
| 2006 Q3 | 84.83 Thousand USD | 11.88% |
| 2006 Q4 | 87.42 Thousand USD | 3.06% |
| 2006 FY | 87.42 Thousand USD | 55.43% |
| 2006 Q2 | 75.82 Thousand USD | 0.0% |
| 2005 FY | 56.24 Thousand USD | 0.0% |
| 2005 Q4 | 56.24 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| BioQuest Corp. | 632.89 Thousand USD | 3.336% |
| GSRX Industries Inc. | - USD | -Infinity% |
| Instadose Pharma Corp. | - USD | -Infinity% |